Rate My Professor Gabrielle McCallum

Gabrielle McCallum has led multiple large NHMRC-funded multi-centre randomised controlled trials and observational studies with multidisciplinary teams extending to New Zealand, Alaska, Malaysia, and Timor-Leste, including the world’s first randomised controlled trials on bronchiolitis in First Nations children. Her work has translated into health policy changes for post-hospitalisation follow-up of bronchiolitis, influenced national and international treatment guidelines, and driven a paradigm shift in paediatric respiratory management across the Northern Territory. She developed and evaluated the first First Nations-specific educational flipcharts for common childhood respiratory conditions such as bronchiolitis, pneumonia, bronchiectasis, and asthma, which have been adapted into the multi-lingual mobile application “Lung Health for Kids”. Key publications include “Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial” (Pediatric Infectious Disease Journal, 2022), “Three-weekly doses of azithromycin for Indigenous infants hospitalised with bronchiolitis: A multi-centre, randomised, placebo-controlled trial” (Frontiers in Pediatrics, 2015), “Antibiotics for persistent cough or wheeze following acute bronchiolitis in children” (Cochrane Database of Systematic Reviews, 2017), and “Comparison of Profiles of First Nations and non-First Nations children with bronchiectasis over two 5-Year periods in the Northern Territory, Australia” (Chest, 2021). In 2017, she received the National Excellence in Education Leadership award in the Women in Leadership category. She serves as a primary supervisor for higher degree by research students.